News

Wyoming Tribune Eagle6d
FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients ...
Fierce Pharma7d
GSK revs up launch plans after Nucala's FDA approval in COPD, targeting £500M opportunity
The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...
Daily Jang4d
Nucala receives FDA approval for COPD
The U.S. Food and Drug Administration has approved Nucala as a supplementary treatment for elderly individuals with severe ...
BioSpace6d
GSK Wins COPD Expansion for Nucala After FDA Delay
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Managed Healthcare Executive6d
FDA Approves Nucala as Maintenance Therapy for COPD
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
MPR6d
FDA Approves Nucala for COPD With an Eosinophilic Phenotype
The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...
Pharm Exec7d
FDA Approves GSK’s Nucala for Chronic Obstructive Pulmonary Disease
Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL. The FDA has approved GSK’s Nucala ...
WebMD7d
FDA OKs Nucala for Hard-to-Treat COPD
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following ...